HK1071436A1 - Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (sars) - Google Patents

Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (sars)

Info

Publication number
HK1071436A1
HK1071436A1 HK05104281A HK05104281A HK1071436A1 HK 1071436 A1 HK1071436 A1 HK 1071436A1 HK 05104281 A HK05104281 A HK 05104281A HK 05104281 A HK05104281 A HK 05104281A HK 1071436 A1 HK1071436 A1 HK 1071436A1
Authority
HK
Hong Kong
Prior art keywords
sars
diagnosing
compositions
methods
acute respiratory
Prior art date
Application number
HK05104281A
Other languages
English (en)
Inventor
Tze Ming Danny Leung
Chi Hang Frankie Tam
Chun Hung Ma
Pak Leong Lim
Kay Sheung Paul Chan
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Publication of HK1071436A1 publication Critical patent/HK1071436A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002—Coronaviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
HK05104281A 2003-09-29 2005-05-23 Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (sars) HK1071436A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50720703P 2003-09-29 2003-09-29

Publications (1)

Publication Number Publication Date
HK1071436A1 true HK1071436A1 (en) 2005-07-15

Family

ID=34794191

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104281A HK1071436A1 (en) 2003-09-29 2005-05-23 Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (sars)

Country Status (3)

Country Link
US (1) US20050112559A1 (zh)
CN (1) CN1609617B (zh)
HK (1) HK1071436A1 (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060128628A1 (en) * 2004-12-15 2006-06-15 Show-Li Chen Human tissue antigen-binding peptides and their amino acid sequences
US8877206B2 (en) 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
CN110075113A (zh) * 2008-04-17 2019-08-02 Pds生物科技公司 通过阳离子脂质的对映体刺激免疫应答
EP4091630A1 (en) 2012-09-21 2022-11-23 PDS Biotechnology Corporation Vaccines comprising r-dotap
JP7326024B2 (ja) * 2019-05-20 2023-08-15 キヤノンメディカルシステムズ株式会社 受診予約支援装置
WO2021147025A1 (en) * 2020-01-22 2021-07-29 The University Of Hong Kong-Shenzhen Hospital Anti 2019-ncov vaccine
BR102021003012A2 (pt) 2020-02-19 2021-11-30 Univ Berlin Charite Métodos para o diagnóstico de infecção por sars-cov-2, kit e usos
LT3869199T (lt) * 2020-02-20 2022-07-11 Euroimmun Medizinische Labordiagnostika Ag Būdai ir reagentai sars-cov-2 diagnostikai
CN111337668A (zh) * 2020-02-27 2020-06-26 四川省人民医院 一种新型冠状病毒抗原胶体金快速诊断试剂盒及其制备方法
CN111505277A (zh) * 2020-03-10 2020-08-07 四川省人民医院 2019新型冠状病毒IgG抗体检测试剂盒
CN111458504A (zh) * 2020-03-12 2020-07-28 中科欧蒙未一(北京)医学技术有限公司 用于检测样品中抗新型冠状病毒SARS-COV-2的IgG抗体的试剂盒
CN113495141A (zh) * 2020-03-20 2021-10-12 迈克生物股份有限公司 2019新型冠状病毒IgM抗体检测试剂盒
CN111366735B (zh) * 2020-03-20 2021-07-13 广州市康润生物科技有限公司 新型冠状病毒更早期筛查方法
CN111187863A (zh) * 2020-03-23 2020-05-22 广州达正生物科技有限公司 一种双酶法恒温扩增检测covid-19的试剂盒和检测方法
CN111781349B (zh) * 2020-04-03 2022-04-22 中国科学院苏州纳米技术与纳米仿生研究所 能够预测covid-19患者预后的诊断试剂盒
EP3892296A1 (en) * 2020-04-07 2021-10-13 InnoMedica Holding AG Immunogenic composition comprising an antigenic moiety and a liposomal formulation, method of producing the composition, the composition for use as a medicament, in particular for use as a vaccine
WO2021209463A1 (en) * 2020-04-14 2021-10-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for detecting the presence of coronavirus-specific antibodies in a subject
US20230296621A1 (en) * 2020-05-11 2023-09-21 Chan Zuckerberg Biohub, Inc. Detection assay for anti-sars-cov-2 antibodies
WO2021250467A2 (en) * 2020-06-08 2021-12-16 Idexx Laboratories, Inc. Detection of antibodies to sars-cov-2
WO2021249010A1 (en) * 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus diagnostic compositions, methods, and uses thereof
US20230314432A1 (en) * 2020-07-10 2023-10-05 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response
CN113945714B (zh) * 2020-07-16 2023-01-31 南京蓬勃生物科技有限公司 新型冠状病毒中和抗体类药物中和能力的检测方法
US11493514B2 (en) * 2020-07-20 2022-11-08 United Arab Emirates University Method and system for virus and protein-antibody interactions detection and monitoring based on optical light intensity and electrical parameters
CN114057845A (zh) * 2020-08-07 2022-02-18 清华大学 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途
WO2022049493A1 (en) * 2020-09-04 2022-03-10 Reagene Innovations Pvt. Ltd. Diagnostic methods for cov2 antigen detection in normal healthy asymptomatic and symptomatic patients at home or at point of care
WO2022175842A1 (en) * 2021-02-17 2022-08-25 Eltek S.P.A. Kit and process for testing a state of immunization in a subject with respect to a pathogenic microorganism
CN112940086B (zh) * 2021-02-26 2022-06-03 深圳市亚辉龙生物科技股份有限公司 新型冠状病毒抗原及其应用
CN116789767B (zh) * 2023-07-12 2023-12-22 中国人民解放军总医院第七医学中心 一种抗新型冠状病毒病多肽组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016132A2 (en) * 2003-07-15 2005-02-24 Temasek Life Sciences Laboratory Limited Diagnostics for sars virus

Also Published As

Publication number Publication date
CN1609617B (zh) 2012-02-15
CN1609617A (zh) 2005-04-27
US20050112559A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
HK1071436A1 (en) Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (sars)
IL171972A0 (en) Compositions and methods for treatment of severe acute respiratory syndrome(sars)
AP2089A (en) Compositions and methods for combination antiviraltherapy
IL217315A0 (en) Tetracycline derivatives and compositions comprising the same
AU2003295511A8 (en) Methods and compositions for diagnosing dysplasia
AU2003262747A8 (en) Compounds, compositions, and methods
EP1503993A4 (en) COMPOUNDS, METHODS AND COMPOSITIONS
AU2003236527A8 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
EP1874379A4 (en) INHALER AND METHOD OF USE
HK1070656A1 (en) Compounds, compositions, and methods
EP1542699A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
AU2003270015A8 (en) Compounds, compositions, and methods
AU2003299612A8 (en) Compounds, compositions and methods
ZA200502843B (en) Methods and compositions for providing glutamine
IL167936A0 (en) Compounds, compositions,and methods
GB2390891B (en) Ventilator
HK1093786A1 (en) Compositions, systems, and methods for imaging
IL172195A0 (en) Thiotungstate analogues and uses thereof
EP1649053A4 (en) CHARACTERIZATION OF THE EARLY LEVELS OF THE VIRUS OF HEAVY ACUTE RESPIRATORY SYNDROME (SARS) AND USES THEREOF
AU2003229474A8 (en) Methods and compositions for detecting sars virus
AU2003290507A8 (en) Compounds, compositions and methods
AU2003277079A8 (en) Compounds, compositions, and methods
AU2003267281A8 (en) Paper compositions, imaging methods and methods for manufacturing paper
AU2003300031A8 (en) Compounds, compositions, and methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160929